ArticleTherapeutic advances in gastroenterology2024

Add-on immunosuppressive therapy may benefit selected patients with primary biliary cholangitis and autoimmune phenomena.

Mengqi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.